Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Weingarden, Alexa R ^a   Dosa, Peter I ^b   DeWinter, Erin ^a   Steer, Clifford J ^a,c   Shaughnessy, Megan K ^c,d   Johnson, James R ^c,d   Khoruts, Alexander ^a,c   Sadowsky, Michael J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d A VA HSR and D Center of Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID; TAUROCHOLIC ACID;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BILE COMPOSITION; CLOSTRIDIUM DIFFICILE INFECTION; COLON; CONCENTRATION (PARAMETERS); CSPC GENE; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; HUMAN; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; RECURRENT INFECTION; SEQUENCE ANALYSIS; SPORE GERMINATION; BIOLOGICAL THERAPY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PROCEDURES;

BILE ACIDS AND SALTS; BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; COLON; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; FECES; HUMANS;

EID: 84958576368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147210     Document Type: Article

References (44)

1. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med. 2008; 359(18):1932-40. doi: 10.1056/NEJMra0707500 PMID: 18971494.
2. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011; 32 (4):387-90. doi: 10.1086/659156 PMID: 21460491.
3. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nature reviews Gastroenterology & hepatology. 2011; 8(1):17-26. doi: 10.1038/nrgastro.2010.190 PMID: 21119612.
4. Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis. 2012; 55 Suppl 2:S65-70. doi: 10.1093/cid/cis319 PMID: 22752867; PubMed Central PMCID: PMC3388017.
5. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012; 107(1):89-95. doi: 10.1038/ajg.2011.398 PMID: 22108454; PubMed Central PMCID: PMC3273904.
6. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA internal medicine. 2013; 173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056 PMID: 23780507.
7. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015; 372(9):825-34. doi: 10.1056/NEJMoa1408913 PMID: 25714160.
8. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011; 364(5):422-31. doi: 10.1056/NEJMoa0910812 PMID: 21288078.
9. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nature reviews Gastroenterology & hepatology. 2012; 9(2):88-96. doi: 10.1038/nrgastro.2011.244 PMID: 22183182.
10. Surawicz CM, Alexander J. Treatment of refractory and recurrent Clostridium difficile infection. Nature reviews Gastroenterology & hepatology. 2011; 8(6):330-9. doi: 10.1038/nrgastro.2011.59 PMID: 21502971.
11. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011; 53(10):994-1002. doi: 10. 1093/cid/cir632 PMID: 22002980.
12. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012; 107 (5):761-7. doi: 10.1038/ajg.2011.482 PMID: 22290405.
13. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368(5):407-15. doi: 10.1056/NEJMoa1205037 PMID: 23323867.
14. Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014; 58(11):1515-22. doi: 10.1093/cid/ciu135 PMID: 24762631; PubMed Central PMCID: PMC4017893.
15. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2010; 44(5):354-60. doi: 10.1097/MCG.0b013e3181c87e02 PMID: 20048681.
16. Shahinas D, Silverman M, Sittler T, Chiu C, Kim P, Allen-Vercoe E, et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. mBio. 2012; 3(5). doi: 10.1128/mBio.00338-12 PMID: 23093385; PubMed Central PMCID: PMC3482503.
17. Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut microbes. 2013; 4(2):125-35. doi: 10.4161/gmic.23571 PMID: 23333862; PubMed Central PMCID: PMC3595072.
18. Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, et al. Recovery of the gut microbiome following fecal microbiota transplantation. mBio. 2014; 5(3):e00893-14. doi: 10.1128/mBio. 00893-14 PMID: 24939885; PubMed Central PMCID: PMC4068257.
19. Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. The ISME journal. 2014; 8(8):1621-33. doi: 10.1038/ismej.2014.13 PMID: 24577353.
20. Shankar V, Hamilton MJ, Khoruts A, Kilburn A, Unno T, Paliy O, et al. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome. 2014; 2:13. doi: 10.1186/2049-2618-2-13 PMID: 24855561; PubMed Central PMCID: PMC4030581.
21. Weingarden A, Gonzalez A, Vazquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, et al. Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 2015; 3:10.doi: 10.1186/s40168-015-0070-0 PMID: 25825673; PubMed Central PMCID: PMC4378022.
22. Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol. 2014; 306(4):G310-9. doi: 10.1152/ajpgi.00282.2013 PMID: 24284963; PubMed Central PMCID: PMC3920123.
23. Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol. 2008; 190(7):2505-12. doi: 10.1128/JB.01765-07 PMID: 18245298; PubMed Central PMCID: PMC2293200.
24. Sorg JA, Sonenshein AL. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol. 2009; 191(3):1115-7. doi: 10.1128/JB.01260-08 PMID: 19060152; PubMed Central PMCID: PMC2632082.
25. Sorg JA, Sonenshein AL. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol. 2010; 192(19):4983-90. doi: 10.1128/JB.00610-10 PMID: 20675492; PubMed Central PMCID: PMC2944524.
26. Giel JL, Sorg JA, Sonenshein AL, Zhu J. Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One. 2010; 5(1):e8740. doi: 10.1371/journal.pone.0008740 PMID: 20090901; PubMed Central PMCID: PMC2806926.
27. Heeg D, Burns DA, Cartman ST, Minton NP. Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts. PLoS One. 2012; 7(2):e32381. doi: 10.1371/journal.pone. 0032381 PMID: 22384234; PubMed Central PMCID: PMC3285209.
28. Wilson KH. Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol. 1983; 18(4):1017-9. PMID: 6630458; PubMed Central PMCID: PMC270959.
29. Arroyo LG, Rousseau J, Willey BM, Low DE, Staempfli H, McGeer A, et al. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J Clin Microbiol. 2005; 43(10):5341-3. doi: 10.1128/JCM.43.10.5341-5343.2005 PMID: 16208013; PubMed Central PMCID: PMC1248507.
30. Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene. 1996; 181(1-2):29-38. PMID: 8973304.
31. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol. 1998; 36 (8):2240-7. PMID: 9665999; PubMed Central PMCID: PMC105025.
32. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol. 2002; 40(9):3470-5. PMID: 12202595; PubMed Central PMCID: PMC130716.
33. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variablenumber tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008; 46(2):431-7. doi: 10.1128/JCM.01484-07 PMID: 18039796; PubMed Central PMCID: PMC2238077.
34. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. ClustalWand Clustal X version 2.0. Bioinformatics. 2007; 23(21):2947-8. doi: 10.1093/bioinformatics/btm404 PMID: 17846036.
35. Moir A, Smith DA. The genetics of bacterial spore germination. Annu Rev Microbiol. 1990; 44:531-53. doi: 10.1146/annurev.mi.44.100190.002531 PMID: 2252393.
36. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005; 353(23):2433-41. doi: 10.1056/NEJMoa051590 PMID: 16322603.
37. Francis MB, Allen CA, Shrestha R, Sorg JA. Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog. 2013; 9(5):e1003356. doi: 10. 1371/journal.ppat.1003356 PMID: 23675301; PubMed Central PMCID: PMC3649964.
38. Khoruts A, Sadowsky MJ, Hamilton MJ. Development of fecal microbiota transplantation suitable for mainstream medicine. Clin Gastroenterol Hepatol. 2014. doi: 10.1016/j.cgh.2014.11.014 PMID: 25460566.
39. Theriot CM, Koenigsknecht MJ, Carlson PE Jr, Hatton GE, Nelson AM, Li B, et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nature communications. 2014; 5:3114. doi: 10.1038/ncomms4114 PMID: 24445449; PubMed Central PMCID: PMC3950275.
40. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2014. doi: 10.1038/nature13828 PMID: 25337874.
41. Koenigsknecht MJ, Theriot CM, Bergin IL, Schumacher CA, Schloss PD, Young VB. Dynamics and Establishment of Clostridium difficile Infection in the Murine Gastrointestinal Tract. Infect Immun. 2014. doi: 10.1128/IAI.02768-14 PMID: 25534943.
42. Mekhjian HS, Phillips SF, Hofmann AF. Colonic absorption of unconjugated bile acids: perfusion studies in man. Dig Dis Sci. 1979; 24(7):545-50. PMID: 456241.
43. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006; 47(2):241-59. doi: 10.1194/jlr.R500013-JLR200 PMID: 16299351.
44. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, et al. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis. 2013; 56 (11):1589-600. doi: 10.1093/cid/cit127 PMID: 23463640; PubMed Central PMCID: PMC3641870.